about
Understanding the impact of 1q21.1 copy number variantMammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain FunctionSpatiotemporal characterization of mTOR kinase activity following kainic acid induced status epilepticus and analysis of rat brain response to chronic rapamycin treatmentThe Mechanistic Target of Rapamycin: The Grand ConducTOR of Metabolism and AgingNeuronal Tsc1/2 complex controls autophagy through AMPK-dependent regulation of ULK1mTORC1 serves ER stress-triggered apoptosis via selective activation of the IRE1-JNK pathwayMammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer diseaseLongevity pathways and memory agingEfavirenz induces neuronal autophagy and mitochondrial alterations.Aging and brain rejuvenation as systemic events.Hot topics in aging research: protein translation and TOR signaling, 2010Reduced neuronal expression of ribose-5-phosphate isomerase enhances tolerance to oxidative stress, extends lifespan, and attenuates polyglutamine toxicity in Drosophila.An emerging role for the Mammalian target of rapamycin in "pathological" protein translation: relevance to cocaine addiction.Cognition and Synaptic-Plasticity Related Changes in Aged Rats Supplemented with 8- and 10-Carbon Medium Chain Triglycerides.Replication-dependent histone genes are actively transcribed in differentiating and aging retinal neurons.MicroRNAs 99b-5p/100-5p Regulated by Endoplasmic Reticulum Stress are Involved in Abeta-Induced Pathologies.The role of mTOR signaling pathway in spinal cord injury.Genomic analysis of sleep deprivation reveals translational regulation in the hippocampus.Age-Related Neurodegeneration Prevention Through mTOR Inhibition: Potential Mechanisms and Remaining Questions.Rapamycin Reduced Ischemic Brain Damage in Diabetic Animals Is Associated with Suppressions of mTOR and ERK1/2 Signaling.Chronic rapamycin treatment or lack of S6K1 does not reduce ribosome activity in vivo.Specific Metabolomics Adaptations Define a Differential Regional Vulnerability in the Adult Human Cerebral Cortex.Consumption of pomegranates improves synaptic function in a transgenic mice model of Alzheimer's disease.A longer and healthier life with TOR down-regulation: genetics and drugs.Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.Insulin and IGF-1 signalling: longevity, protein homoeostasis and Alzheimer's disease.The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis.Modulating macroautophagy: a neuronal perspective.mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis.Brain response to calorie restriction.The impact of age on oncogenic potential: tumor-initiating cells and the brain microenvironment.Targeting the mTOR signaling network for Alzheimer's disease therapy.Mechanisms of action of brain insulin against neurodegenerative diseases.Signaling pathway cross talk in Alzheimer's diseaseProtein recycling pathways in neurodegenerative diseases.Calorie restriction and stroke.New perspectives on the involvement of mTOR in depression as well as in the action of antidepressant drugs.mTOR signaling contributes to motor skill learning in mice.Branched-Chain Amino Acids and Brain Metabolism.Decreased mTOR signalling reduces mitochondrial ROS in brain via accumulation of the telomerase protein TERT within mitochondria.
P2860
Q21202865-67330C12-9BAF-43EB-93CE-DCC6AB163F14Q26744655-0ABF2AC8-7180-4281-A89C-994E433B1C6BQ27318635-4853EE91-AB23-4B4A-8FC9-D8A810FB71B1Q28276378-3B2A28E2-21BE-4DB7-BA58-0A851799D854Q28575722-5D21D55B-F970-43D7-BC03-CCEF938D24EBQ28583302-C0F503D8-AB20-4A5E-B59E-38BAA27C9DC9Q30412891-D619CAE0-FC69-4737-8660-9719FF6CD5F1Q33709311-795DFA44-3C8A-4611-8460-30F6B519A72DQ34360731-B9F144F1-E1B2-4EE3-985E-4468C683507AQ34444118-3C2A452B-52B1-4663-B0A7-C824F527FDD1Q34669340-A44F3482-5928-43AF-8A0C-E98B0B4AB21CQ35670371-13E27965-D531-4D77-8B0B-B4EEF42B577AQ35738367-AE50C5B8-4737-4CDF-BCDF-7578CA367C28Q36102614-5498143A-4033-4C9E-8860-55C6322DA1CAQ36189243-B74EC54A-EFE6-4E8A-9261-C5447D3209C8Q36290224-25899296-9A11-415E-8681-8C881E054D21Q36304099-E2D5DF99-7B46-4CFD-9F03-B89B63BB9ED8Q36320739-28D6559F-73CE-4A66-8DFA-1F7176B14C68Q36614145-7682374A-C686-4455-BEA1-79F7443AFAACQ37148571-9521104B-3970-481B-96BB-3FD502711188Q37344807-3248EA0F-A4BE-470D-9688-C6BDFC2C644FQ37483166-10277D56-7B65-4B3C-A47B-4F4730901510Q37662094-4C2DA1DB-D2CD-4DF8-988B-AA887D2B102AQ37856372-03F0AB29-5C55-4A7D-8E38-8F57A59FBF5CQ37981491-7BB4E78D-DF7B-4E05-80D3-B7E8D613805BQ38027944-21D36123-DD1A-48C1-93CE-7E13F3097884Q38028872-2ACE3F5B-2F47-4E0A-AAA2-4664E70354C9Q38038228-5085F1AE-99D8-4049-BF19-D6DCBA2353A1Q38050335-BDB9B8CE-39FB-4CDF-8D8B-A33EA8DB0774Q38069942-363A73F8-A94C-42C7-85CA-4CB32015D9C6Q38109711-40AA4975-4143-492F-A3FD-85FC1E46268EQ38121524-DCB9F12C-8832-4DBD-B71E-495CEC40290EQ38176522-04D0D108-81A4-43AD-BF99-C59DEED1ABB1Q38200151-51432C6C-8705-44F2-AD98-65FEA3191AF9Q38230383-1053DBCE-3A55-4100-8BEC-279478BC3736Q38557903-5CF86C77-C3EC-4CD9-93C4-B55DC8344B6BQ38650284-6D58D0FF-76EF-475B-BC5A-E4E4395A8490Q38688038-BDDD8852-2064-4C24-815B-50E404F9FBB3Q39247363-AD43DB8E-527B-4A0C-813B-C38BC1B00B94Q39252929-2988AA70-8022-48BB-A8FF-8EE2AA794199
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TOR on the brain.
@en
TOR on the brain.
@nl
type
label
TOR on the brain.
@en
TOR on the brain.
@nl
prefLabel
TOR on the brain.
@en
TOR on the brain.
@nl
P2860
P1476
TOR on the brain
@en
P2093
Michael G Garelick
P2860
P304
P356
10.1016/J.EXGER.2010.08.030
P577
2010-09-16T00:00:00Z